Scientists may have overlooked a hidden Alzheimer's culprit for decades
For decades, researchers have invested billions of dollars in Alzheimer's treatments designed to target amyloid beta, a peptide that forms harmful deposits in the brain. But a biochemist at the University of California, Santa Cruz, believes scientists may have overlooked another potential contributor to the disease: a smaller, closely related peptide that was long considered harmless.
Alzheimer's is the most widespread neurodegenerative disease, affecting approximately 35 million people worldwide and generating annual costs exceeding $800 billion. The number of people living with the condition is expected to double by 2050.
Read the original report
Opens ScienceDaily in a new tab